يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"Andriy Rusyn"', وقت الاستعلام: 1.00s تنقيح النتائج
  1. 1
    Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial

    المؤلفون: Justin Stebbing, V. Baryash, Alexandru Eniu, Joanna Pikiel, S. Young Lee, Francisco J. Esteva, S. Yu, Yauheni Valerievich Baranau, R. K. Li, Sang Joon Lee, Daniil Stroyakovskiy, Andriy Rusyn, Dmytro Boliukh, B. Tiangco, Vladimir Moiseyenko, Giorgi Dzagnidze, Edvard Zhavrid, Alexey Manikhas

    المصدر: Cancer Chemotherapy and Pharmacology
    BASE-Bielefeld Academic Search Engine

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Toxicology, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Antineoplastic Agents, Immunological, Breast cancer, Trastuzumab, Pharmacology (medical), Pharmacology & Pharmacy, PATHOLOGICAL COMPLETE RESPONSE, Stage (cooking), skin and connective tissue diseases, Complete response, Adjuvant, Early breast cancer, ADJUVANT TRASTUZUMAB, Biosimilar, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Original Article, Drug Monitoring, 1115 Pharmacology and Pharmaceutical Sciences, Life Sciences & Biomedicine, medicine.drug, HER2 positive, medicine.medical_specialty, Breast Neoplasms, 03 medical and health sciences, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Adverse effect, CT-P6, Biosimilar Pharmaceuticals, neoplasms, Neoplasm Staging, Pharmacology, Heart Failure, Science & Technology, business.industry, medicine.disease, CONTROLLED SUPERIORITY TRIAL, 030104 developmental biology, Heart failure, business, FOLLOW-UP

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a736241d66b19d88c6d6890756b98e
    http://hdl.handle.net/10044/1/74318

    أضف إلى المفضلة
  2. 2
    Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma : Updated results from the FAST trial

    المؤلفون: Martin Schuler, Assen Dudov, Salah-Eddin Al-Batran, Özlem Türeci, Andriy Rusyn, Florian Lordick, Daniel Maurus, Kai Wiechen, Igor Bondarenko, Igor Bazin, Karl Dhaene, Bohuslav Melichar, Georgy M. Manikhas, Ihor Vynnychenko, Ugur Sahin

    مصطلحات موضوعية: Cancer Research, Tight junction, business.industry, Cell, Medizin, medicine.disease, Gastroesophageal Junction, Epitope, Malignant transformation, 03 medical and health sciences, 0302 clinical medicine, First line therapy, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, Gastric mucosa, Medicine, Adenocarcinoma, business, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d7f3f1ace08a055530b511c8f75af1

    أضف إلى المفضلة
  3. 3
    Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia

    المؤلفون: Gopinath Ranganna, Leonard A. Mattano, Mudgal Kothekar, Katrin Beckmann, István Láng, Iryna Lytvyn, Yaroslav Shparyk, Cornelius F. Waller, Mark Baczkowski, Eduardo J. Pennella, Rajiv Sharma, Christopher Blakeley, Oleksandr Berzoy, Vasil Popov, Andriy Rusyn, Miguel H. Bronchud, Nataliia Voitko, Abhijit Barve

    المصدر: Annals of hematology. 98(5)

    مصطلحات موضوعية: Adult, medicine.medical_specialty, Cyclophosphamide, Filgrastim, medicine.medical_treatment, Breast Neoplasms, Neutropenia, Polyethylene Glycols, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Chemotherapy-Induced Febrile Neutropenia, Biosimilar Pharmaceuticals, Aged, Chemotherapy, business.industry, Incidence, Hematology, General Medicine, Middle Aged, medicine.disease, Equivalence Trial, Docetaxel, 030220 oncology & carcinogenesis, Absolute neutrophil count, Female, business, Febrile neutropenia, Pegfilgrastim, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42727e0c1652598a3cb304d9f26380d6
    https://pubmed.ncbi.nlm.nih.gov/30824956

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  4. 4
    CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

    المؤلفون: Andriy Rusyn, Vladimir Moiseyenko, Valeriy Baryash, Dmitry Komov, Dmytro Boliukh, Daniil Stroyakovskii, Sang Joon Lee, Edvard Zhavrid, Justin Stebbing, Joanna Pikiel, Giorgi Dzagnidze, Yauheni Valerievich Baranau, Sung Young Lee, Alexandru Eniu, Rubi K. Li, Gabriela Morar-Bolba, Alexey Manikhas, Francisco J. Esteva

    المساهمون: Medical Research Council (MRC), Imperial College Trust, Action Against Cancer, Breast Cancer Care & Breast Cancer Now, Cancer Research UK, Eisai Europe Ltd, Imperial College Healthcare NHS Trust- BRC Funding, Pink Ribbon Foundation, Worldwide Cancer Research, Imperial College Healthcare Charity, Wellcome Trust, National Institute for Health Research

    المصدر: The Lancet. Oncology. 18(7)

    مصطلحات موضوعية: 0301 basic medicine, Receptor, ErbB-2, medicine.medical_treatment, Docetaxel, PACLITAXEL, PLUS TRASTUZUMAB, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, PATHOLOGICAL COMPLETE RESPONSE, Neoadjuvant therapy, Mastectomy, ADJUVANT TRASTUZUMAB, education.field_of_study, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, Neoadjuvant Therapy, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Taxoids, Fluorouracil, Life Sciences & Biomedicine, medicine.drug, Epirubicin, Adult, medicine.medical_specialty, PARALLEL HER2-NEGATIVE COHORT, Population, Breast Neoplasms, BIOSIMILAR MONOCLONAL-ANTIBODIES, Adenocarcinoma, CLINICAL-TRIAL, 03 medical and health sciences, Breast cancer, Double-Blind Method, Internal medicine, medicine, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, education, Adverse effect, Biosimilar Pharmaceuticals, Cyclophosphamide, Aged, Febrile Neutropenia, Neoplasm Staging, Science & Technology, business.industry, medicine.disease, CONTROLLED SUPERIORITY TRIAL, Surgery, 030104 developmental biology, NEOADJUVANT TREATMENT, business, Febrile neutropenia

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4307529393a7a2271c09b1be158cfbe8
    https://pubmed.ncbi.nlm.nih.gov/29129095

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  5. 5
    Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers : Results from the FAST study

    المؤلفون: Karl Dhaene, Salah-Eddin Al-Batran, Bohuslav Melichar, Georgy M. Manikhas, Assen Dudov, Ihor Vynnychenko, Florian Lordick, Kai Wiechen, Martin Schuler, Özlem Türeci, Zanete Zvirbule, Daniel Maurus, Andriy Rusyn, Igor Bazin, Ugur Sahin

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Tight junction, business.industry, Medizin, Gastroesophageal Junction, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, Gastric mucosa, Medicine, Claudin, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f9e82e7db95b882e2b482527f286d5

    أضف إلى المفضلة
  6. 6
    Rectal cancer – estimation of the quality life in patients after radical surgery

    المؤلفون: Kostiantyn Rumiantsev, Andriy Rusyn, Vasyl Rusyn

    المصدر: Novosti Khirurgii. 21:84-89

    مصطلحات موضوعية: Surgery

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::664debe3889e97ae58e91614acca9679
    https://doi.org/10.18484/2305-0047.2013.4.84

    أضف إلى المفضلة
  7. 7
    Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive early breast cancer (EBC)

    المؤلفون: Zakaria Zautashvili, V. Baryash, Rubi Khaw Li, Gabriela Morar-Bolba, Daniil Stroyakovskiy, Francisco J. Esteva, Dmitry Komov, Joanna Pikiel, Andriy Rusyn, Dmytro Boliukh, Igor Lifirenko, Alexey Manikhas, Vladimir Moiseyenko, Sang Joon Lee, Justin Stebbing, Sung Young Lee, Alexandru Eniu, Giorgi Dzagnidze, Edvard Javrid, Yauheni Valerievich Baranau

    المصدر: Journal of Clinical Oncology. 35:510-510

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, Cyclophosphamide, business.industry, medicine.medical_treatment, Biosimilar, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, Docetaxel, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, Relative risk, medicine, Clinical endpoint, skin and connective tissue diseases, business, neoplasms, Adjuvant, medicine.drug, Epirubicin

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a3a4edf2258e09a54b2b8a87c5df3295
    https://doi.org/10.1200/jco.2017.35.15_suppl.510

    أضف إلى المفضلة
  8. 8
    FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma

    المؤلفون: Marina Nechaeva, Assen Dudov, Martin Schuler, Salah-Eddin Al-Batran, Zanete Zvirbule, Ugur Sahin, Christoph Huber, Yuriy Vynnyk, Andriy Rusyn, Natalia Fadeeva, Florian Lordick, Igor Bondarenko, Igor Bazin, Ihor Vynnychenko, Georgiy Manikhas, Christian Mueller, Alexander Pecheniy, Ö. Türeci, Evgeny Gotovkin, Bohuslav Melichar

    المصدر: Journal of Clinical Oncology. 34:LBA4001-LBA4001

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Cancer, medicine.disease, Oxaliplatin, Capecitabine, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, Cancer cell, biology.protein, Medicine, Adenocarcinoma, Antibody, business, medicine.drug, Epirubicin

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2f9f7babf7a4da78ea88a25a470619
    https://doi.org/10.1200/jco.2016.34.18_suppl.lba4001

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    inferior vena cava collapsibility index as a non-invasive method of assessing the volemic status of patients during spine interventions.

    المؤلفون: Ivachevskyj, M. M., Rusyn, A. V., Ivachevska, V. V.

    المصدر: Orthopaedics, Traumatology & Prosthetics / Ortopediia, Traumatologiia i Protezirovaniie; 2024, Issue 1, p33-37, 5p

    مصطلحات موضوعية: VENA cava inferior, CENTRAL venous pressure, CENTRAL venous catheterization, LAMINECTOMY, SPINE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).

    المؤلفون: Prasad, Sandip M., Huang, William C., Shore, Neal D., Hu, Brian, Bjurlin, Marc, Brown, Gordon, Genov, Pencho, Shishkov, Dimitar, Khuskivadze, Alexandre, Ganev, Tosho, Marchev, Dobri, Orlov, Igor, Kopyltsov, Evgeny, Zubarev, Vadim, Nosov, Alexander, Komlev, Dmitrii, Burger, Brent, Raju, Sunil, Meads, Andrew, Schoenberg, Mark

    المصدر: Journal of Urology; Oct2023, Vol. 210 Issue 4, p619-629, 11p

    View record from ScienceDirect View record in Lippincott, Williams & Wilkins
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء